Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer Journal Article


Authors: Herr, H. W.; Scher, H. I.
Article Title: Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer
Abstract: Purpose: This clinical trial evaluated a bladder-sparing strategy using a combined modality approach of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy followed by a partial cystectomy for patients with invasive (T2-4N0M0) bladder cancer. Patients and Methods: One hundred eleven surgical candidates received a median of four cycles of neoadjuvant M-VAC. Following treatment, of those with a favorable response to chemotherapy based on cystoscopic examination, 26 underwent a partial cystectomy. Results: Of 26 patients, 17 (65%) are alive beyond 5 years (median, 6.9 years; range, 4 to 8), including 14 (54%) with an intact, functioning bladder. Twelve patients (46%) developed bladder recurrences, which were invasive in five (18%) and superficial in seven (26%). Patients with no (P0) or noninvasive (Pis) tumor in their surgical specimens had a 5- year survival rate of 87% (14 of 16), compared with 30% (three of 10) among patients with residual invasive cancer. The majority of deaths was attributed to preexisting metastases. Conclusion: Neoadjuvant M-VAC chemotherapy permitted bladder-sparing surgery in selected responding patients with invasive bladder neoplasms. The bladder remained at risk for new tumor development, but local recurrences were treated successfully by local therapy or salvage cystectomy.
Keywords: adult; aged; cancer surgery; major clinical study; clinical trial; cisplatin; doxorubicin; cancer risk; multimodality cancer therapy; cancer adjuvant therapy; methotrexate; cancer staging; bladder cancer; vinblastine; cancer invasion; cystectomy; bladder carcinogenesis; human; male; female; priority journal; article
Journal Title: Journal of Clinical Oncology
Volume: 12
Issue: 5
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 1994-05-01
Start Page: 975
End Page: 980
Language: English
DOI: 10.1200/jco.1994.12.5.975
PROVIDER: scopus
PUBMED: 8164050
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr
  2. Howard Scher
    1130 Scher